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Vivien W. F. Chan,*² Fanying Meng,§ Philippe Soriano,‖ cellular proteins, phosphatidylinositol turnover, and Ras
activation. The most rapid response is increased proteinAnthony L. DeFranco,*²³ and Clifford A. Lowell§
*Department of Biochemistry and Biophysics tyrosine phosphorylation, which is thought to initiate all
of thesubsequent signalingevents. Some of theproteins²George Williams Hooper Foundation
³Department of Microbiology and Immunology known to be tyrosine phosphorylated upon BCR en-
gagement include the receptor components Ig-a and§Department of Laboratory Medicine
University of California Ig-b; the transmembrane proteins CD19 and CD22; and
numerous signaling components such as Shc, rasGAP,San Francisco, California 94143
‖Division of Molecular Medicine mitogen-activated protein (MAP) kinase, phosphatidyl-
inositol-3 kinase, phospholipases C-g1 and C-g2, SHP-1Fred Hutchinson Cancer Research Center
Seattle, Washington 98104 and Vav (reviewed by DeFranco, 1993). Three distinct
types of tyrosine kinases have been found to be phos-
phorylated as well as activated upon BCR signaling:
Lyn, Blk, Fyn, Lck, and Fgr of the Src-family (Burkhardt etSummary
al., 1991; Yamanashi et al., 1991; Wechsler and Monroe,
1995); Syk of the Syk/ZAP-70 family (Hutchcroft et al.,Lyn-deficient mice were generated to analyze the role
1992; Burg et al., 1994); and Btk of the Tec family (Aokiof Lyn in B cell antigen receptor (BCR) signaling. These
et al., 1994; Saouaf et al., 1994). A multistep model formice had a reduced number of peripheral B cells with
BCR signaling has been proposed (DeFranco, 1995) ina greater proportion of immature cells and a higher
which the Src-family kinases are the first to be activatedthan normal turnover rate. Aged lyn2/2 mice developed
upon receptor engagement and phosphorylate the tyro-splenomegaly, produced autoantibodies, and had an
sine residues in the ITAM sequences within Ig-a andexpanded population of B lymphoblasts of the B1 lin-
Ig-b. The phosphorylated ITAMs recruit the binding ofeage. Splenic B cells from young lyn2/2 mice initiated
Syk, which becomes phosphorylated and activated.early BCR signaling events, although in adelayed fash-
Both the Src-family kinases and Syk are likely to contrib-ion. Unexpectedly, lyn2/2 B cells exhibited anenhanced
ute to the phosphorylation and/or activation of down-MAP kinase activation and an increased proliferative
stream effectors (Takata et al., 1994; Nagai et al., 1995).response to BCR engagement. Stimulation of lyn2/2 B
Among the Src-family kinases, Lyn is widely ex-cells with intact and F(ab9)2 anti-IgM revealed defects
pressed in hematopoietic cells (Bolen et al., 1992; Lawin at least two mechanisms that negatively regulate
et al., 1992) and has been implicated in a variety ofBCR signaling, one of which involves FcgRIIb1.
biochemical experiments to be involved in BCR signal-
ing. BCR engagement induces rapid increases in theIntroduction
tyrosine phosphorylation and kinase activity of Lyn (Burk-
hardt et al., 1991). In addition, Lyn has been found toA functional immune system has to maintain the ability
associate with the BCR complex upon BCR crosslinkingto recognize a large diversity of foreign antigens while
(Law et al., 1993 and references therein). The predictedminimizing self-reactivity. Depending on the maturation
optimal substrate-recognition sequence for Lyn is alsostate of the B lymphocyte and signals supplied by other
consistent with its being a kinase that can phosphorylatecells such as helper T cells, antigen binding can lead to
the ITAMs in the BCR complex (Schmitz et al., 1996).the physical or functional elimination of autoreactive B
To test directly the importance of Lyn for BCR signaling,cells or the proliferation and differentiation of B cells
we have generated mice deficient for Lyn by targetedrecognizing foreign antigens (Goodnow et al., 1995, Ra-
disruption of the active lyn gene. B cells develop in thesejewsky, 1996). Antigen binding also appears to partici-
mice butexhibit a numberof abnormalities. For example,pate in the positive selection of B lymphocytes into the
aged lyn2/2 mice have an activated B cell populationperipheral mature B cell pool (Cyster et al., 1996). There-
that appears to be of the B1 lineage. In contrast tofore, the study of the molecular events triggered by
results from a previous study (Nishizumi et al., 1995),antigen binding is important for understanding how sig-
we found that early BCR signaling events in lyn2/2 Bnaling from the same receptor can lead to such diverse
cells were delayed but not drastically impaired. Unex-consequences.
pectedly, BCR crosslinking in lyn2/2 B cells led to aThe B cell antigen receptor (BCR) consists of mem-
greater activation of the MAP kinase pathway comparedbrane immunoglobulin (Ig) complexed with Ig-a/Ig-b di-
to wild-type B cells, and this correlated with an en-mers, the former providing antigen recognition and the
hanced proliferative response to anti-IgM treatment inlatter mediating signaling functions (Reth, 1994). Studies
lyn2/2 B cells. Mechanisms that inhibit BCR signaling,using chimeric transmembrane proteins have shown
such as those mediated by the receptor for the Fc regionthat conserved sequences, known as the immunorecep-
of IgG (FcgRIIb1), are defective in lyn2/2 B cells. Thustor tyrosine-based activation motif (ITAM), within the
Lyn, in addition to participating in the initiation of thecytoplasmic domains of Ig-a and Ig-b are responsible
BCR signal, also stimulates events that negatively regu-for transducing BCR intracellular signaling events (Sef-
late certain BCR-induced signaling reactions and theton and Taddie, 1994). The biochemical events triggered
by BCR signaling include increased phosphorylation of resulting B cell proliferation.
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Results Appearance of Autoantibodies and B Cell
Blasts in Aged lyn2/2 Mice
Both heterozygous and homozygous littermates ap-Targeted Disruption of the lyn Gene
peared healthy and were fertile under specific-patho-In the mouse, there are two loci that encode lyn se-
gen±free conditions. However, homozygous lyn2/2 micequences, one being the full-length active lyn gene, and
were found to develop autoantibodies and plasma cellthe other being a nonexpressed pseudogene (Hibbs et
accumulation with age, similar to what has been pre-al., 1995a). Within the shared regions, the active lyn gene
viously reported with independently generated micecan be distinguished from the pseudogene by sequence
(Hibbs et al., 1995b; Nishizumi et al., 1995). When wild-differences in the coding exons and a slightly different
type and lyn2/2 mice at various ages were tested for therestriction map (Figure 1A). We used a gene-targeting
presence of serum autoantibodies recognizing nuclearconstruct that deleted exons 3±7 of the active gene and
antigens or double-stranded DNA (dsDNA), the lyn2/2replaced these sequences with a pol2s-neo expression
mice started to become positive around 16 weeks ofcassette (Soriano et al., 1991). This construct was elec-
age (Table I). Both IgM and IgG antibodies to dsDNAtroporated into ES cells, and clones that had undergone
were found among the autoantibodies that developed.homologous recombination into the active locus were
lyn2/2 mice older than 14 weeks also developed sple-selected for blastocyst injection. The alteration of the
nomegaly. Histological sections of these enlarged spleens
active locus was confirmed by Southern blot analysis
revealed the presence of large numbers of immature
of DNA isolated from the mice (Figure 1B) and also by
myeloid cells, fully differentiated neutrophils, lympho-
a polymerase chain reaction (PCR) assay (Figure 1C), blasts, and plasmacells (C. A. L., V. W. F. C., and A. L. D.,
which enabled us to followthe mutation duringbreeding. unpublished data). Splenomegaly was often accompa-
lyn transcripts were detected by Northern blot analy- nied by an enlargement of the lymph nodes with
sis in wild-type bone marrow cells but not in lyn2/2 cells lymphoblasts and plasma cells. Examination of cells
(Figure 1D). Immunoblot analysis of bone marrow cell from these enlarged lymph nodes by flow cytometry
lysates using an antibody specific for exon 2±encoded revealed the presence of an IgM1Mac-11CD51 popula-
sequences (regions not within the deletion) showed that tion in lyn2/2 mice (R1 in Figures 2A and 2C) that was
the mutation resulted in the loss of both the p53 and found neither in wild-type mice of similar age (Figure
p56 forms of Lyn, and no truncated protein forms could 2A) nor in young lyn2/2 mice (data not shown). These
be detected (Figure 1E). This confirmed that the disrup- cells appeared to be activated, as indicated by their
high forward light-scattering property (an assessmenttion produced a true loss-of-function mutation.
Figure 1. Targeted Mutation of the Active lyn Gene Results in Animals Deficient for Lyn
(A) Restriction maps that we generated for both the lyn pseudogene and the active lyn gene are shown along with the targeting vector used
to inactivate the functional gene. Numbered boxes represent the exons. Restriction sites: X, XbaI; B, BamHI; and H, HindIII.
(B) Southern blot analysis of tail biopsy DNA from offsprings of lyn1/2 parents. The 10 kb fragment represents hybridization to the lyn
pseudogene, as determined by its molecular weight and its alteration in size in mice that contain a targeted mutation within the pseudogene.
The unmutated active lyn gene produces a 9 kb fragment, while the mutated allele results in a 6 kb fragment.
(C) PCR genotyping of offspring from lyn1/2 parents. Primers (indicated in A) were specific for the active lyn allele or for the neo insert and
produced a 340 bp or a 415 bp PCR product, respectively.
(D) Northern blot analysis of RNA from bone marrow macrophages indicated that the predicted 3.2 kb band for lyn mRNA was present only
in the wild-type cells, despite equal loading of RNA (not shown).
(E) Immunoblot analysis of whole-cell lysates (25 mg) from bone marrow cells isolated from wild-type, lyn1/2, and lyn2/2 mice.
Lyn-Deficient B Cells
71
Table 1. Presence of Autoantibodies in Serum
Antibodies to nuclear antigensa Age (weeks) lyn2/2 (n) Wild-Type (n)
5±7 0 (9) 0 (5)
8±10 1 (8) 0 (5)
11±13 2 (11) ND
14±15 1 (7) ND
16±18 4 (5) ND
19±21 8 (9) 0 (6)
22±32 3 (3) 0 (6)
Antibody Isotype
Anti-dsDNA antibodies in lyn2/2 miceb Age (weeks) (n) IgM IgG
6±9 (10) 0.224 6 0.088 0.018 6 0.015
10±13 (10) 0.434 6 0.161 0.098 6 0.082
14±16 (12) 0.528 6 0.239 0.513 6 0.436
17±20 (7) 0.859 6 0.222 0.876 6 0.478
a Data shown as number of mice whose serum scored positive for antibodies against nuclear antigens, of a total of n mice tested.
b Data shown as the mean 6 SE of n mice per age group. Values represent ELISA readings in A450 (triplicate samples per animal) after 30 min
of color development. Greater variation was seen in IgG isotypes because some animals had very low anti-dsDNA autoantibodies of the IgG
isotype. Wild-type mice had no detectable anti-dsDNA autoantibodies at any age.
ND, not done.
of cell size) (Figure 2B). The fact that they stained posi- the B220loHSAhi stage, but fewer mature B cells were
present in the periphery.tively for IgM, Mac-1, and CD5 suggests that these may
be B cell blasts derived from cells of the B1 lineage
(Hardy et al., 1994). In addition, these cells were also B Cells in lyn2/2 Mice Have a Higher
Turnover Ratefound to be B220loIgD2, consistent with their identity as
B1 cells (data not shown). One possible explanation for the decreased percentage
of mature B cells in the lyn2/2 mice is that a larger portion
of newly generated peripheral B cells failed to enter theConventional B Cells in lyn2/2 Mice Have a
More Immature Surface Phenotype long-lived B cell pool, which would be reflected by an
increased rate of B cell turnover. To test this hypothesisAnother observation that could bemade from the data in
Figure 2 is a decrease in the proportion of conventional directly, we examined the in vivo incorporation of
5-bromo-29-deoxyuridine (BrdU) into splenic and lymphB cells (R2 in Figure 2A) in these aged lyn2/2 mice. A
decreased number of conventional B cells was also ob- node B cells in 9-week-old mice. In the lymph nodes
from wild-type mice, 20% of B2201 lymphocytes wereserved in lyn2/2 mice that had not yet developed spleno-
megaly. Consistent with published data on other lyn2/2 BrdU1 by day 8 (Figure 4A). The sizeof this newly synthe-
sized B cell population remained at 17%±25% for themice (Hibbs et al., 1995b; Nishizumi et al., 1995), our
lyn2/2 mice had a reduced peripheral B cell population rest of the experiment (up to 22 days), indicating that
at least 75% of the B2201 lymphocytes in wild-type(generally 50%±70% of wild-type levels [n 5 30]), a sig-
nificant reduction in the number of recirculating B cells lymph nodes were long-lived B cells with a lifetime of
greater than 3 weeks. During the first 8 days of thein the bone marrow (Figure 3A), and a decrease in the
conventional B cell population in the peritoneum (data experiment, B lymphocytes in the lymph nodes from
lyn2/2 mice labeled with BrdU at a rate similar to wildnot shown). These observations led us to postulate a B
cell maturational defect and prompted examination of type. However, in contrast to the wild type, which ap-
peared to level off after 8 days of labeling, the percent-the expression level of the heat-stable antigen (HSA) on
B cells. B cells that are B220loHSAhi are recent emigrants age of labeled cells in the lyn2/2 mice continued to in-
crease. Thus, while 20%±25% of the B lymphocytes infrom the bone marrow that subsequently develop into
more mature B220hiHSAlo cells while in the periphery wild-type lymph nodes were short-lived B cells, at least
45% of those in the lyn2/2 mice were short-lived. The(Allman et al., 1993; Carsetti et al., 1995). As shown in
Figure 3B, while the percentage of B220loHSAhi lympho- percentage of short-lived splenic B lymphocytes was
also higher in lyn2/2 mice than in wild-type mice althoughcytes in the bone marrow, spleen, and lymph nodes
were similar in wild-type and lyn2/2 mice, lyn2/2 mice had the magnitude of the difference was less than in lymph
node (Figure 4B). These labeling experiments, togethera 2- to 5-fold reduction in the percentage of B220hiHSAlo
B lymphocytes in these lymphoid compartments. Con- with the phenotypic analysis, indicate that lyn2/2 B cells
exhibit a defect either in the maturation to the long-livedsistent with the HSA expression data, lyn2/2 mice also
had more IgMhiIgDlo and fewer IgMloIgDhi cells in the mature state or in the survival of mature B cells.
spleen and peripheral blood (data not shown). Examina-
tion of the expression of other surface markers such as Anti-IgM±Induced Tyrosine Phosphorylation
in lyn2/2 B CellsCD43(S7) confirmed that early B lineage cells in the bone
marrow were present in comparable numbers in wild Genetic disruption of lyn in a chicken B cell line resulted
in decreased levels of BCR-induced tyrosine phosphor-type and lyn2/2 mice (data not shown). Thus, B cell pro-
duction appeared to be normal in the lyn2/2 mice until ylation (Takata et al., 1994). It was therefore of interest
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with maximal response also at about 5 mg/ml of goat
anti-IgM. This 55 kDa protein may correspond toanother
Src-family tyrosine kinase, such as Blk, which has also
been reportedto be phosphorylated upon BCR signaling
(Burkhardt et al., 1991). The levels and activities of other
Src-family kinases present in B cells, Blk, Hck, Fgr, and
Fyn, were the same in wild-type and lyn2/2 B cells, as
determined by immunoblotting and in vitro kinase
assays (data not shown). A protein (* in Figure 5) migrat-
ing just above the 64 kDa marker in this gel system was
less robustly phosphorylated in the anti-IgM±stimulated
lyn2/2 B cells than in wild-type B cells. This protein was
found to comigrate with Syk upon reprobing of the nitro-
cellulose blot with an anti-Syk antibody (Figure 5B).
To examine whether the absence of Lyn might affect
the rate at which the BCR signal is relayed, we stimu-
lated purified splenic B cells with goat anti-IgM for
varying lengths of time. Whereas wild-type B cells had
already attained a maximal level of tyrosine phosphory-
lation by 1 min of stimulation, the response in lyn2/2 B
cells did not peak until 3 min after stimulation (Figure
5D). A number of proteins, such as Syk and Shc and
the membrane Ig accessory molecules, Ig-a and Ig-b,
have been reported to have increased tyrosine phos-
phorylation upon BCR activation (DeFranco, 1995). Syk
immunoprecipitated from stimulated cells often runs as
a doublet because of phosphorylation (Richards et al.,
1996). As shown in Figure 5G, Ig-a, Syk, and Shc immu-Figure 2. Surface Phenotype of Lymph Node Cells from 23-Week-
noprecipitated from wild-type lysates exhibited aOld Mice
marked increase in tyrosine phosphorylation after 3 minThe lyn2/2 mice had developed splenomegaly and lymphadenopathy
by this age. Cells were triple-stained with antibodies to IgM, Mac-1, of stimulation, and the degree of phosphorylation
and CD5 and analyzed by flow cytometry. slightly decreased by 20 min. A 3 min stimulation of
(A) The IgM1Mac-11 and IgM1Mac-12 populations are indicated by lyn2/2 B cells resulted in a less dramatic increase in the
regions R1 and R2, respectively. Cells in R2 correspond to the
phosphorylation of Ig-a, Syk, and Shc compared to wildconventional B cell population.
type, and the signals never exceeded wild-type levels(B) The forward light scatter (FSC) of the cells within R1 and R2 are
even by 20 min of stimulation. These delayed responsesrepresented as histograms.
(C) The CD5 staining of cells in R1 and R2. The areas under the two observed in the absence of Lyn are consistent with the
curves within each panel in (B) and (C) are directly proportional to model that Lyn participates in the initiation of the anti-
the number of cells present in each population. IgM induced signal and acts upstream of Syk in BCR
signaling (Kurosaki et al., 1994; DeFranco, 1995). Al-
though the absence of Lyn resulted in a slightly longer
to examine whether the same defect was observed in lag time to reach a maximal signal, anti-IgM±induced
splenic B cells from the lyn2/2 mice. As mentioned above, signaling events can nevertheless be initiated, perhaps
the accumulation of myeloid cells and activated B1 B by other members of the Src-family tyrosine kinases
cells in lyn2/2 mice older than 14 weeks ledto theconcern that are present in the lyn2/2 B cells.
that environmental perturbations such as secreted cyto-
kines could affect the properties of splenic B cells from
these mice. Therefore, all of the experiments below were Induction of B7-2 on lyn2/2 B Cells by
Lipopolysaccharide and Anti-IgMperformed with cells from mice that were 7±11 weeks
of age without any signs of splenomegaly. Stimulation of B cells via the BCR or by the polyclonal
B cell activator, lipopolysaccharide (LPS), has beenAnti-IgM stimulation of purified splenic B cells from
both wild-type and lyn2/2 mice caused a dose-depen- shown to induce the expression of the T cell costimula-
tory molecules B7-2 and, at later times, B7-1 (Lenschowdent increase in tyrosine phosphorylation of cellular pro-
teins (Figure 5A). Two prominently tyrosine-phosphory- et al., 1994). Therefore, we tested whether the induced
expression of B7-2 on B cells is affected by the lyn2/2lated proteins in wild-type cells flanking the 55 kDa
molecular weight marker were distinctly absent in the mutation. Nonerythroid splenocytes from wild-type and
lyn2/2 mice were cultured in vitro in the presence of anti-lyn2/2 cells. These proteins were confirmed to be the
p53 and p56 forms of Lyn (Figure 5C). A stimulation- IgMover a wideconcentration range, and theexpression
of B7-2 on B cells was assessed by flow cytometricdependent increase in the tyrosine phosphorylation of
Lyn and a 55 kDa protein can be observed in wild-type analysis after 18 hr. The percentage of lyn2/2 B2201 cells
induced to express B7-2 was similar to that of wildB cells, most noticeably at a 5 mg/ml dose of goat anti-
IgM. A similar increase in the tyrosine phosphorylation type at all anti-IgM concentrations tested (Figure 6A).
However, the average intensity of the B7-2 staining (asof a 55 kDa protein can also be observed in lyn2/2 cells,
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Figure 3. Surface Phenotype of Conven-
tional B Lymphocytes
Bone marrow, spleen, and lymph node cells
from 8-week old wild type and lyn2/2 mice
were stained for B220, IgM, and HSA simulta-
neously and analyzed by flow cytometry.
(A) B220 3 IgM profiles of cells in the lympho-
cyte gate. The B220hiIgMmed population in the
bone marrow corresponds to recirculating B
lymphocytes and is indicated by the dotted-
line boxes.
(B) Distinct populations of B220hiHSAlo and
B220loHSAhi cells were observed in the bone
marrow. The boxes drawn around these two
populations in the bone marrow were also
used for the analysis of the cells in the spleen
and the lymph node. The percentage of lym-
phocytes that lie within each boxed region is
indicated.
measured by the mean fluorescence channel) on the proliferation of purified splenic B cells following LPS or
anti-IgM stimulation. As shown in Figure 6D, wild-typeB7-21 cells was slightly higher in lyn2/2 than in wild-type
cells when stimulated at intermediatedoses of goat anti- and lyn2/2 B cells exhibited similar proliferative re-
sponses to LPS. In contrast, lyn2/2 B cells were signifi-IgM (0.8±4 mg/ml) (data not shown), similar to observa-
tions made independently by others (A. Tarakhovsky, cantly more sensitive to anti-IgM than wild-type B cells,
as indicated by a shift in the anti-IgM dose±responsepersonal communication).
LPS has been reported to stimulate Lyn activity in curve (Figure 6C). The maximal difference was observed
macrophages (Stefanova et al., 1993) but not in B cells at 2.5 mg/ml anti-IgM, where the level of [3H]dT incorpo-
(Burkhardt et al., 1991). To assess whether the response ration in lyn2/2 B cells was 4.5 times that of wild-type B
of B cells to LPS was affected by the lyn2/2 mutation, cells. To confirm that the increased proliferation ob-
B7-2 expression induced by LPS was also examined served in lyn2/2 cells was attributable to the B cells and
(Figure 6B). When stimulated with LPS, a slightly lower not to the small percentage of contaminating non±B
percentage of lyn2/2 B cells expressed B7-2 as com- cells in our splenic B cell preparations, we used flow
pared to wild type, but the difference was never greater cytometric analysis to assess the in vitro proliferation of
than 18%. B2201 cells by their ability to incorporate BrdU. Whereas
the wild-type and lyn2/2 B cells exhibited equal prolifera-
lyn2/2 B Cells Display a Hypersensitive tive responses to various concentrations of LPS (Figure
Growth Response to Anti-IgM 6F), the lyn2/2 B cells again proliferated at lower concen-
To examine further the effects of the lyn2/2 mutation trations of anti-IgM than did the wild-type B cells (Figure
on biological responses of B cells, we assessed the 6E). The hypersensitivity of lyn2/2 B cells to anti-IgM was
not due to a defect in receptor down-regulation, since
the rate of internalization of surface IgM upon receptor
crosslinking was the same for both wild-type and lyn2/2
B cells (data not shown).
Anti-IgM Causes Enhanced Stimulation of the
MAP Kinase Pathway in lyn2/2 B Cells
The enhanced proliferative response of the lyn2/2 B cells
to anti-IgM stimulation was unexpected in light of the
finding that most early BCR signaling events were de-
layed and slightly decreased (Figures 5D and 5G). Since
the duration of MAP kinase activation has been shown
to be important for the proliferative/differentiation re-
Figure 4. Turnover of Peripheral B Lymphocytes sponses of cells in other systems (reviewed by Marshall,
Continuous administration of BrdU to 9-week old wild-type (closed 1995), we tested whether the BCR-induced activation
circles) and lyn2/2 (open circles) mice was initiated on day 0. At each of MAP kinases in B cells was altered in the absence
indicated time point, three mice of each group were sacrificed and of Lyn. BCR signaling has previously been shown to
the proportion of B2201 lymphocytes in the (A) lymph nodes and
activate a fraction of the total cellular pool of the extra-(B) spleen that was labeled with BrdU (mean6 SEM) was determined
cellular signal±regulated protein kinase 2 (ERK2) formby flow cytometric analysis. These data are representative of two
independent experiments. of MAP kinase in B lymphoma lines (Gold et al., 1992)
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Figure 6. Biological Responses of Wild-Type and lyn2/2 B Cells to
LPS and Anti-IgM
Unpurified splenocytes (A and B; E and F) or purified splenic B cells
(C and D) from wild-type (closed circles) and lyn2/2 (open cir-
cles) mice were cultured with various concentrations of goat anti-
IgM or LPS.
(A and B) Splenocytes were incubated with media or with stimuli
for 18 hr prior to staining and flow cytometric analysis. The data
presented (mean 6 SE) are the proportion of viable cells (as deter-
mined by forward light scatter and propidium iodide exclusion) that
were B2201 and positively stained for B7-2.
(C and D) Purified splenic B cells were incubated with media or with
stimuli for 44 h and subsequently pulsed with [3H]dT for 4 hr.
(E and F) Splenocytes were incubated with media or with stimuli for
24 hr and then labeled with 1 mM BrdU for the following 24 hr. The
proportion of B2201 cells that incorporated BrdU (mean 6 SE) was
determined by flow cytometric analysis. The data shown are repre-Figure 5. Protein Tyrosine Phosphorylation upon Anti-IgM Stimula-
sentative of two or more independent experiments each involvingtion of Purified Splenic B Cells
at least two mice of each genotype.
(A) Anti-phosphotyrosine immunoblot of whole-cell lysates of cells
treated with media alone or different concentrationsof goat anti-IgM
for 3 min at 378C. (D) Anti-phosphotyrosine immunoblot of whole-cell
as well as in purified splenic B cells (Cyster et al., 1996).lysates of cells treated with media alone or 20 mg/ml anti-IgM at
This activation is accompanied by an increase in tyro-378C for the indicated length of time (in minutes). Regions of the
sine phosphorylation of ERK2 and a decrease in its mo-nitrocellulose blot in (A) and (D) corresponding to 60±75 kDa and
50±60 kDa were stripped and reprobed with anti-Syk (B and E) and bility on an SDS-polyacrylamide gel (Gold et al., 1992).
anti-Lyn (C and F) antibodies, respectively. The anti-Syk immunoblot As shown in Figure 7A, a greater fraction of ERK1 and
serves as an internal control for equivalent loading between the ERK2 shifted to a slower mobility in lyn2/2 B cells than
lanes as well as for determining the positions of Syk in (A) and (D)
in wild-type cells following anti-IgM treatment. It is note-(asterisks). (G) Purified splenic B cells were treated with media alone
worthy that at low doses of anti-IgM (1.25±5 mg/ml),or goat anti-IgM at 20 mg/ml at 378C for 3 or 20 min. The indicated
there was little or none of the more slowly migratingproteins were immunoprecipitated from 250 mg of each lysate and
analyzed by anti-phosphotyrosine immunoblotting. Equivalent load- forms of ERK1 and ERK2 in wild-type cells, while there
ing between the lanes was verified by stripping and reprobing the was a substantial amount induced in lyn2/2 cells. This
immunoblots with the corresponding antibodies (data not shown). is a striking parallel to the proliferation experiments, in
which the maximal difference was also observed in this
concentration range of anti-IgM (Figures 6C and 6E).
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Figure 7. Enhanced Activation of the MAP
Kinase Pathway in lyn2/2 B Cells by Anti-IgM
Stimulation
Purified splenic B cells were stimulated as
described in Figure 5.
(A and B) The 35±50 kDa regions of the immu-
noblots shown in Figures 5A and 5D respec-
tively, which were stripped and reprobedwith
an antibody that recognizes both the ERK1
and ERK2 forms of MAP kinase. The more
slowly migrating forms of ERK1 and ERK2 are
indicated as ERK1* and ERK2*, respectively.
(C±I) Purified splenic B cells from wild-type
and lyn2/2 mice were treated with media alone
or indicated concentrations of goat anti-IgM
for 3 min at 378C. ERK2 was immunoprecipi-
tated from 40 mg of each lysate and subjected
to an in vitro kinase assay using Elk-1 (C) or
MBP (D) as substrates. The 35±55 kDa region
of the SDS±polyacrylamide gel electrophore-
sis shown in (D) was transfered to nitrocellu-
lose and immunoblotted with an antibodythat
recognizes only the dually phosphorylated
(active) forms of MAP kinases (E). The immu-
noblot in (E) was subsequently stripped and
reprobedwith thesame anti-MAPkinase anti-
body used in (A) and (B) above to verify equiv-
alent loading (F). Note that the gel systems
used in (A) and (B) and (C)±(F) are different;
only the former enables the resolution of the
active forms of MAP kinases to slower mobili-
ties. MEK1 was also immunoprecipitated
from 40 mg of each lysate and subjected to
an in vitro kinase assay using recombinant
(G) kinase inactive ERK2 or (H) kinase active ERK2 as substrates. The in vitro activation of recombinant ERK2 by MEK1 was assayed by its
ability to phosphorylate MBP in a coupled kinase assay (I). The levels of 32P incorporation were quantitated using a PhosphorImager and
represented as relative activity with respect to the unstimulated wild-type sample (first lane).
Time course experiments indicated that although a kinase activation were also enhanced in lyn2/2 B cells,
MAP kinase kinase/ERK kinase 1 (MEK1) activation wasgreater fraction of ERK1 and ERK2 in lyn2/2 B cells
shifted to slower mobility upon anti-IgM stimulation as next examined. MEK1 activity was assayed either by in
vitro kinase assays using catalytically inactive ERK2 ascompared to wild-type B cells, the peak response was
observed at 1 to 3 min of anti-IgM stimulation in both a substrate (Figure 7G) or by a coupled kinase assay
(Figures 7H and 7I). Again, anti-IgM caused greater in-wild-type and lyn2/2 B cells (Figure 7B). However, the
more slowly migrating forms of MAP kinases appeared creases in MEK1 activation in lyn2/2 B cells than in wild-
type B cells at all doses of anti-IgM examined.topersist for a longer period in lyn2/2 Bcells as compared
to wild-type (Figure 7B). In other experiments in which
longer stimulation times were examined (up to 36 hr), Enhanced Responses of lyn2/2 B Cells to Anti-IgM
in the Presence and Absence ofthe amount of more slowly migrating forms of ERK1 and
ERK2 observed was always higher in lyn2/2 B cells than Fcg-Receptor Coligation
The enhancedactivation of the MAP kinase pathway andin wild type (data not shown).
To confirm that the appearance of the more slowly proliferative response to anti-IgM suggested a defect
in signal down-regulation in lyn2/2 B cells. One of themigrating forms of the MAP kinases seen upon BCR
engagement corresponded to increases in kinase activi- mechanisms by which the BCR signal is negatively regu-
lated involves FcgRIIb1. When FcgRIIb1 iscoligated withties, we assayed for ERK2 kinase activity in vitro using
myelin basic protein (MBP) and a GST fusion to the Ets the BCR using intact rabbit anti-Ig antibodies, B cell
proliferation, phosphatidylinositol turnover, and trans-domain protein (Elk-1) as substrates. Anti-IgM stimula-
tion of lyn2/2 B cells consistently led to significantly membrane calcium influx are inhibited (reviewed by
DeFranco and Law, 1995). To test whether the FcgRIIb1-greater increases in ERK2 kinase activities compared
to wild-type B cells, the difference being most dramatic mediated inhibition is defective in lyn2/2 B cells, the
proliferative responses of wild-type and lyn2/2 B cells toat low doses of anti-IgM (Figures 7C and 7D and data
from four other experiments not shown). The enhanced intact rabbit anti-IgM was examined (Figure 8A, top).
Rabbit anti-IgM at doses greater than 1 mg/ml wasactivation of ERK2 in lyn2/2 B cells was also demon-
strated by increased formation of phosphorylated ERK2 clearly mitogenic to lyn2/2 B cells, while wild-type B
cells exhibited only a very weak proliferative response,upon anti-IgM treatment as compared to wild type (Fig-
ure 7E). indicating that Fcg receptor±mediated inhibition is defec-
tive in lyn2/2 B cells.To test whether signaling events upstream of MAP
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Figure 8. Enhanced Responses of lyn2/2 B Cells to BCR Signaling in the Presence and Absence of FcgR-Mediated Inhibition
RBC-depleted splenocytes (A) or purified splenic B cells (B and C) were preincubated with media alone, or with media containing the anti-
FcgR monoclonal antibody (2.4G2) for 30 min.
(A) The splenocytes were plated out at 0.5 3 106 per ml and cultured with rabbit anti-IgM, goat anti-IgM or goat F(ab9)2 anti-IgM at the indicated
concentrations. The proportion of B2201 cells that incorporated BrdU (mean 6 SE) between 24 and 48 hr poststimulation was determined by
flow cytometric analysis.
(B and C) Anti-ERK1/2 and anti-Syk immunoblots of whole-cell lysates of purified splenic B cells treated with media, goat anti-IgM (B) or goat
F(ab9)2 anti-IgM (C) for 3 min at 378C. Note that the goat anti-IgM antibodies used in the experiments in this figure belonged to a batch different
from that used in the preceding figures. The affinity of this batch of antibodies appeared to be lower and resulted in a decreased level of
stimulation as compared to prior experiments at comparable doses. Data shown are representative of two or three experiments with the same
batch of antibodies.
To examine this issue further, cells were pretreated Fcg receptor by the antibody treatment, goat F(ab9)2
fragments of anti-IgM antibodies were used (Figure 8A,with a blocking monoclonal antibody against Fcg recep-
tors, 2.4G2. As expected, wild-type B cells exhibited a bottom). lyn2/2 B cells were found to proliferate better
than wild-type B cells, even in the absence of Fcg recep-strong proliferative response to rabbit anti-IgM when the
Fcg receptor±negative signal was blocked with 2.4G2. tor involvement, indicating that othernegative regulation
mechanisms might be defective in lyn2/2 B cells.lyn2/2 B cells that were pretreated with the anti-Fcg re-
ceptor antibody also proliferated better than untreated To test whether the enhanced proliferation observed
upon Fcg receptor blockage is accompanied by a corre-lyn2/2 B cells, indicating that some negative signaling
could still be mediated by the Fcg receptor in lyn2/2 B sponding increase in MAP kinase activation, purified
splenic B cells were pretreated with the anti-Fcg recep-cells. Interestingly, rabbit anti-IgM induced proliferation
remained higher in lyn2/2 B cells than in wild-type B cells, tor antibody and stimulated with various concentrations
of intact goat anti-IgM (Figure 8B). Anti-MAP kinase im-even when both cell types were pretreated with anti-
Fcg receptor antibody (Figure 8A, top). This suggests munoblot revealed that anti-Fcg receptor antibody pre-
treatment resulted in the appearance of greater amountsthat inhibitory mechanisms other than those mediated
by Fcg receptors might also be defective in lyn2/2 B cells. of the more slowly migrating ERK1 and ERK2 in both
wild-type and lyn2/2 B cells. Thus, the activation of MAPA similar experiment was also carried out with intact
goat anti-IgM antibodies (Figure 8A, middle). Goat anti- kinases also appears to be negatively regulated by Fcg
receptor signaling. Again theamounts of the more slowlybodies interact with murine Fcg receptors less well than
do rabbit antibodies, but some Fcg receptor inhibition of migrating forms of MAP kinases were consistently
higher in lyn2/2 B cells as compared to wild-type B cellsB cell proliferation was evident. Again, the proliferative
response of lyn2/2 B cells was greater than the response when stimulated under identical conditions. In parallel
with the enhanced proliferation of lyn2/2 B cells in re-of wild-type B cells even in the presence of anti-Fcg
receptor antibody. To rule out the possibility that these sponse to F(ab9)2 fragments of anti-IgM antibodies (Fig-
ure 8A, bottom), greater amounts of the more slowlydifferences were due to an incomplete blockage of the
Lyn-Deficient B Cells
77
migrating forms of MAP kinases were also observed in The ability of coligated FcgRIIb1 to down-regulate
BCR signaling involves the phosphorylation of a tyrosinelyn2/2 B cells as compared to wild-type B cells.
in the cytoplasmic domain of FcgRIIb1 (Muta et al.,
1994). One attractive possibility is that Lyn may be im-
Discussion portant for carrying out this phosphorylation (Bewarder
et al., 1996). Tyrosine-phosphorylated FcgRIIb1 serves
Mice deficient in Lyn exhibit defects in several different as a binding site for p145SHIP, an inositol phosphatase,
lineages of hematopoietic cells (Hibbs et al., 1995b). which appears to be an inhibitory signaling component
In the work described here, we have focused on the (Ono et al., 1996). The phosphorylated tyrosine of
characterization of the B cell populations in lyn2/2 mice. FcgRIIb1 also serves as a binding site for the recently
These mice have a reduced peripheral B cell population renamed SH2-containing tyrosine phosphatase, SHP-1
but at the same time exhibit an accumulation of B cell (D'Ambrosio et al., 1995; Adachi et al., 1996). SHP-1 may
blasts and serum autoantibodies. We have extended then act to dephosphorylate one or more key signaling
previous observations by demonstrating that the B cell components participating in BCR signaling. Interest-
blasts seen in older mice express CD5 and Mac-1 and ingly, SHP-1 also binds to CD22 in an inducible fashion
therefore appear to be of the B1 lineage. Moreover, the (Doody et al., 1995), consistent with the possibility that
conventional B cell population in lyn2/2 mice has an CD22 mediates the additional negative regulatory event
increased proportion of less mature B cells and exhibits that is absent in lyn2/2 B cells.
a higher turnover rate. To try to understand the possible The negative role of SHP-1 in regulating antigen re-
causes of these in vivo B cell abnormalities, we have ceptor responses of B cells has been indicated by stud-
examined the signaling and biological responses to BCR ies of Bcells in motheaten viable mice (Cyster and Good-
stimulation of resting splenic conventional B cells. now, 1995b), which have a mutation in the gene
We observed a delayed time course for the BCR- encoding SHP-1. Defects in the motheaten mice, such
induced tyrosine phosphorylation of some proteins in as the hyperproliferative response to anti-IgM and the
whole-cell lysates, including Ig-a and Syk (Figures 5D impaired FcgRIIb1-mediated inhibition in their B cells
and 5G), consistent with the model that Lyn participates (D'Ambrosio et al., 1995; Pani et al., 1995), as well as
in the initiation of the BCR signaling cascade (DeFranco, the decreased numbers of conventional B cells, the acti-
1995). Lyn appears to be the most highly expressed of vation and expansion of B1 cells, the development of
the Src-family tyrosine kinases in splenic B cells, so it splenomegaly and neutrophilia, the appearance of auto-
is not surprising that its absence noticeably affects this antibodies, and the accumulation of large numbers of
step in BCR signaling. Although the induction of tyrosine plasma cells (Shultz and Green, 1976; Davidson et al.,
phosphorylation of some proteins required a longer lag 1979; Sidman et al., 1986) were all mirrored in lyn2/2
time in the absence of Lyn, the BCR signal can neverthe- mice. These striking phenotypic similarities suggest that
less be initiated, probably by other Src-family kinases Lyn and SHP-1 might lie along common signaling path-
that are still present in the lyn2/2 cells. On the other hand, ways for signal down-regulation, as postulated above.
the enhanced activation of MEK1 and the MAP kinases BCR signaling induces the tyrosine phosphorylation
(Figure 7) and the hypersensitive proliferative response of Shc, and the subsequent formation of the Shc/Grb2/
to intact and F(ab9)2 fragments of anti-IgM antibodies in Sos complex is thought to mediate the activation of Ras
lyn2/2 B cells suggested that Lyn might also participate and MAP kinase (Saxton et al., 1994; Kumar et al., 1995).
in the down-regulation of the BCR signal by inhibitory In light of the delayed induction of tyrosine phosphoryla-
mechanisms. Thus, while other Src-family kinases might tion on Shc in lyn2/2 cells (Figure 5G), it was surprising
be able to compensate for Lyn in signal initiation, the to find enhanced activation of the MAP kinases (Figure
role of Lyn in signal down-regulation appears to be non- 7). One possible explanation for this discrepancy would
redundant. be that the Shc/Grb2/Sos pathway may not be the sole
The striking observation that rabbit anti-IgM induced mediator of BCR-induced MAP kinase activation in B
considerable proliferation of lyn2/2 B cells in contrast to cells. A precedent for this possibility is that the protein
the weak proliferation of wild-type B cells indicates that kinase C agonist PMA has been shown in a human B
the inhibitory signal through FcgRIIb1 is largely defective cell line to activate the Raf-1/MEK1 pathway without the
in the absence of Lyn (Figure 8A). However, this prolifer- induction of Shc tyrosine phosphorylation or Shc/Grb2
ation of lyn2/2 B cells was enhanced somewhat when Fcg association (Kumar et al., 1995). Whether there is en-
receptors were blocked, indicating that some negative hanced activation of the protein kinase C±dependent
signaling from FcgRIIb1 remains. Moreover, when the pathway leading to MAP kinase activation by anti-IgM
involvement of FcgRIIb1 was avoided by stimulating the in the lyn2/2 B cells has yet to be determined.
B cells with F(ab9)2 fragments of anti-IgM, lyn2/2 B cells By measuring cell proliferation using two independent
still responded better than wild-type B cells, suggesting methods, we demonstrated that lyn2/2 B cells proliferate
that another inhibitory pathway is also likely to be defec- at lower doses of anti-IgM than wild-type B cells (Figures
tive in lyn2/2 B cells. One candidate for this additional 6C and 6E). Doses of goat anti-IgM that resulted in the
inhibitory mechanism is CD22, since the prevention of most dramatic differences in proliferation corresponded
CD22 coaggregation with the BCR lowers the threshold to anti-IgM doses at which wild-type B cells exhibited
for BCR-induced proliferation (Pezzutto et al., 1987; much lower MAP kinase activation than lyn2/2 B cells
Doody et al., 1995) and since B cells from CD22-deficient (Figure 7A). In addition to the magnitude of MAP kinase
mice are hyperresponsive to BCR signaling (O'Keefe et activation, the duration of this response was also found
to be greater in lyn2/2 B cells (Figure 7B and data notal., 1996).
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shown). The duration of MAP kinase activation has been maturation (Cyster et al., 1996). Because Lyn has been
shown to be involved in many early BCR signalingshown in other cell systems to be critical for cell fate
decisions (Traverse et al., 1994). Therefore, it is attrac- events, it is attractive to postulate that the poor matura-
tion of B cells in lyn2/2 mice may reflect impairment oftive to think that the enhanced activation of MAP kinase
in the lyn2/2 B cells contributes to the hyperproliferative a signal normally required for positive selection of B
cells. However, in light of the enhanced MAP kinaseresponse to anti-IgM. It is also worth noting that the
increased proliferation of lyn2/2 B cells appears to be signaling seen in lyn2/2 B cells, it is also possible that a
greater fraction of B cells are deleted or anergized inspecific for BCR-signaling, since the LPS dose±
response curves for wild type and lyn2/2 B cell prolifera- lyn2/2 mice as a result of their signaling above a certain
threshold when they come into contact with normallytion were very similar (Figures 6D and 6F).
In contrast to our findings presented here, others ini- nontolerizing self-antigens (Cyster and Goodnow, 1995a;
Goodnow, 1996). Since anergic B cells have shorter half-tially reported an impaired proliferative response of
lyn2/2 B cells to both anti-IgM and LPS treatment (Hibbs lives in the presence of competing B cells, this may
account for the increased B cell turnover rate andet al., 1995b; Nishizumi et al., 1995), as well as a reduc-
tion in many early biochemical signaling responses to the decreased proportion of mature B cells observed
in lyn2/2 mice. Introduction of various immunoglobulinanti-IgM (Nishizumi et al., 1995). The discrepancy be-
tween the initial published reports and our findings may transgenes into the lyn2/2 genetic background will en-
able the testing of these possibilities. In any case, it isbe attributable to the fact that lyn2/2 mice develop sple-
nomegaly. We found that the accumulation of plasma already apparent that studies of lyn2/2 mice will provide
a number of insights not only into Lyn function, but alsocells, neutrophils, and hematopoietic progenitors in the
enlarged spleens of older lyn2/2 mice made it difficult to into the roles of BCR signaling in B cell maturation and
activation.purify B cells without substantial numbers of contami-
nating B2202 cells. The extramedullary hematopoiesis
and autoantibody production occurring in these mice Experimental Procedures
might also be accompanied by environmental changes
that could affect the responses of their splenic B cells. Generation of lyn2/2 Mice
A targeting vector was made from DNA encoding the active lyn geneTherefore, all of ourbiochemical and proliferative experi-
by replacing a BamHI to HindIII fragment encompassing exons 3±7ments were performed with B cells from mice that were
with a pol2s-neo cassette (Soriano et al., 1991). A thymidine kinasebetween 7 and 11 weeks old without any signs of spleno-
expression cassette was added downstream from the short arm of
megaly. More recently, Wang et al. (1996) reported that the vector for selection against cells with nonhomologous integra-
B cells purified from 4- to 8-week-old lyn2/2 mice have tion events. This construct (20 mg) was electroporated into 107 ES
cells, and cells were subjected to neomycin and/or FIAU (1-(29-an enhanced proliferative response to anti-Ig, similar to
deoxy-29-fluoro-b-D-arabinofuranosyl)-5-iodouracil) selection aswhat we observed. They also found that the proliferation
described (Soriano et al., 1991). Negative selection produced aof lyn2/2 B cells is not inhibited by coligation of the
9-fold reduction in the number of G418 resistant clones. ThirtyFcgRIIb1 with the BCR, in agreement with our results.
NeorFIAUr colonies were screened by PCRfor homologous recombi-
In older lyn2/2 mice, there is marked expansion of nation into the active locus. The PCR primers used for detection of
activated B1 cells and considerable production of auto- homologous recombination were derived from sequences in the 39
portion of the neo insert and in exon 8 of the active gene. The se-antibodies. The B1 population in normal mice is gener-
quences used were ª39neoº: 59-GCATCGCCTTCTATCGCCTTCTTGated from B cell precursors early in life and is maintained
ACG-39 and ªexon 8º: 59-CAGACTTCCCCAAACTGCCCTGCGCC-39.by self-renewal. This population exhibits an increase in
PCR conditions were 948C for 1 min, 608C for 1 min, and 658C forthe proportion of cells with autospecificity as animals
3 min for 40 cycles as described (Soriano et al., 1991). Of these
age, possibly due to antigen-based selection (Hardy et colonies, 12 had homologous insertion of the vector into the active
al., 1994). Mutation of genes encoding signaling compo- locus. Six of these clones were expanded, and all were confirmed to
have a homologous replacement of the active lyn gene by Southernnents involved in positively regulating the BCR signal,
blotting, in which genomic DNA was digested with XbaI, electropho-such as Syk, Btk, CD19 and Vav, leads to a loss of the
resed, transferred to nylon membranes, and hybridized with aB1 population (Cheng et al., 1995; Engel et al., 1995;
32P-labeled probe isolated from downstream of exon 8 of the activeKhan et al., 1995; Rickert et al., 1995; Tarakhovsky et
lyn gene. These 6 clones were injected into C57BL/6J blastocysts,
al., 1995; Turner et al., 1995; Zhang et al., 1995). These giving rise to four different chimeric mouse lines that subsequently
observations suggest that certain BCR signaling events passed the mutation to offspring. Analysis of lyn2/2 homozygous
are required for the maturation or maintenance of B1 mice derived from different ES clones had similar phenotypes, con-
firming that none of the effects observed was due to mutations incells. Thus, one attractive hypothesis is that BCR signal-
other sites in the genome.ing in the B1 cells of lyn2/2 mice also causes enhanced
To facilitate screening for the lyn mutation during breeding, weMAP kinase activation and proliferation, similar to that
designed a PCR assay that was specific for the active gene. Se-
observed for the splenic conventional B cells, leading quence analysis revealed a short region between exon 4 and exon
to the activation and expansion of B1 cells in lyn2/2 mice. 5 that was absent in the pseudogene. A PCR primer from this region
Although the early development of conventional B (59-CATAGCCTGAGTTAGTTCCCTAGC-39) was paired with an-
other primer (59-TCACATATGAACATGTGTGTACATGTC-39) andcells in lyn2/2 mice occurs normally, subsequent matura-
produced a 340 bp fragment only from the active gene. To scoretion of immature B cells to enter the long-lived mature
for the mutated allele, two PCR primers, 39neo (as above) and anB cell population is adversely affected by the lyn2/2 mu-
exon 7 primer: 59-AGCCACCATTGTCCAGACTTC-39 were used.
tation (Figures 3 and 4). Studies of the maturation of PCR conditions for tail DNA were 948C for 45 sec, 558C for 45 sec,
CD452/2 B cells carrying the anti-lysozyme immuno- and 728C for 1 min for 35 cycles in standard Perkin-Elmer PCR
globulin transgenes suggest that a low level of BCR buffer.
Northern blot analysis was carried out using total RNA (10 mg)signaling provides a positive signal that promotes B cell
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isolated from bone marrow macrophages cultured from wild-type In Vitro [3H]dT Incorporation
Purified splenic B lymphocytes (2.0 3 105 per 200 ml) were culturedor lyn2/2 mice. The RNA was electrophoresed on a 1% formaldehyde
gel, transferred to nylon, and hybridizedwith the full-length lyn cDNA in triplicate or quadruplicate in the presence of anti-IgM or LPS at
various concentrations in tissue culture medium. The cells wereclone.
pulsed with [3H]dT (1 mCi/well) from 44 to 48 hr poststimulation and
harvested onto glass fiber filters (Wallac, Gaithersburg, MD), and theAntibodies and Other Reagents
amount of [3H]dT incorporated was determined using the BetaplateAffinity-purified anti-Lyn antibody raised against the N-terminal
reader (Wallac).unique domain of p56lyn which recognizes both the p53 and p56
forms of Lyn has been described (Law et al., 1993). Anti-Shc anti-
body was affinity purified from rabbits immunized with human Shc Surface Expression of B7-2
RBC-depleted splenocytes (2 3 106) from 7-week old wild-type andexpressed as a GST fusion protein (S.L. Harmer and A.L.D., unpub-
lished data). This antibody crossreacts with murine Shc in immu- lyn2/2 mice were cultured at 0.5 3 106 cells/ml in the presence of
various concentrations of LPS or anti-IgM for 18 hr. Cells werenoblots as well as immunoprecipitations. Affinity-purified goat-anti-
mouse IgM (whole IgG and F(ab9)2) and rabbit-anti-mouse IgM (whole costained with B220 and B7-2 and analyzed by flow cytometric
analysis. The B7-2±negative gate was defined by cells that wereIgG) were obtained from Jackson Immunological Research (West
Grove, PA). LPS from Salmonella minnesota R595 was purchased stained by a control antibody.
from List Biological (Campbell, CA). Cultured supernatants from
HO13.4 (anti-Thy1), 53.6.172 (anti-CD8), GK1.5 (anti-CD4), and 2.4G2 Immunoprecipitations and Immunoblotting
(anti-FcgRII) were generated from hybridomas obtained from ATCC. Purified splenic B lymphocytes were resuspended to 8 3 106 per
Antibodies obtained from Pharmingen (San Diego, CA) included ml of medium at 378C. Preparation of cell lysates (40 3 106 per
biotinylated M1/69 (anti-HSA), phycoerythrin (PE)±conjugated RA3± ml), immunoblotting, and immunoprecipitations were carried out as
6B2 (anti-B220), PE-conjugated GL-1 (anti-B7-2) and PE-conjugated previously described (Crowley et al., 1996) except that the lysis
1G10 (anti-B7-1). Fluorescein isothiocyanate±conjugated anti-BrdU buffer contained 1% deoxycholate in addition to 1% Triton X-100.
was obtained from Becton-Dickinson. Avidin-TriColor and biotinyl- The amount of protein in the detergent-soluble lysates was quanti-
ated anti-CD5 were obtained from CalTag (South San Francisco, tated by bicinchoninic assays (Pierce, Rockford, IL). Whole-cell ly-
CA). Anti-MEK1, anti-ERK2 used for immunoprecipitation (C-14) and sates were analyzed on 10% SDS-polyacrylamide gels containing
the antibody that recognizes both ERK1 and ERK2 in immunoblots an acrylamide:bis-acrylamide ratio of 120:1 (Figures 5A±5F; 7A and
(K-23) were obtained from Santa Cruz Biotechnology (Santa Cruz, 7B; and 8B and 8C). The phosphorylated forms of MAP kinases shift
CA). The antibody that recognizes only the dually phosphorylated to a slower mobility under this low-bis gel system. Immunoprecipi-
forms of ERK1 and ERK2 was obtained from Promega (Madison, tates were analyzed on 10% SDS-polyacrylamide gels (acryl-
WI). Tissue culture medium used in all experiments was RPMI 1640 amide:bisacrylamide ratio 37.5:1) (Figure 5G). Proteins were trans-
supplemented with 5% FCS (Gibco±BRL), 2 mM pyruvate, 20 mM ferred to nitrocellulose membranes and immunoblotted with 4G10.
glutamine, and 50 mM 2-mercaptoethanol. To verify equivalent loading or to detect specific proteins, the mem-
branes were stripped with 100 mM 2-mercaptoethanol, 2% SDS,
62.5 mM Tris (pH 6.7) for 15 min at room temperature and blockedFlow Cytometric Analysis
Analysis was performed on a FACScan (Becton Dickinson) and the with 5% milk before the addition of specific primary antibodies, and
detected as described (Crowley et al., 1996).data acquired to a Macintosh Quadra running CellQuest v2.1
software.
ERK2 and MEK1 Kinase Assays
ERK2 immunoprecipitates were washed twice with lysis buffer andBrdU Labeling
In Vivo Labeling once with kinase assay buffer (30 mM b-glycerolphosphate, 20 mM
HEPES (pH 7.2), 20 mM MgCl2, 5 mM EGTA, 1 mM dithiothreitol,BrdU (Sigma) was administered in drinking water to 9-week old wild-
type and lyn2/2 mice. The drinking water, which was protected from and 1 mM Na3VO4). The kinase reaction was initiated by adding 25
ml of kinase assay buffer containing 1 mCi 32P-g-ATP with 25 mg oflight, contained 0.25 mg/ml BrdU and 2.5% glucose and was
changed every 3±4 days. Single cell suspensions from the bone MBP (Sigma) or 10 mg of Elk-1 (New England Biolabs, Beverly, MA)
as substrates and incubated at 308C for 15 min. MEK1 activity wasmarrow, spleen, axillary, and mesenteric lymphnodes were depleted
of red blood cells (RBCs) and stained for HSA, B220, and BrdU as assayed either by a GST fusion to catalytically inactive ERK2 (Up-
state Biotechnology, Lake Placid, NY) as substrate or by coupledpreviously described (Hartley et al., 1993). The stained cells were
analyzed on a FACScan. Data collection for each sample was termi- kinase assays using recombinant rat ERK2 (Calbiochem, La Jolla,
CA) and MBP. Assays were carried out at 308C for 15 min usingnated when 20,000 events within the B2201 gate were acquired.
The acquired data were analyzed by gating on small lymphocytes buffer conditions as described in the kinase cascade assaykit proto-
col from Upstate Biotechnology. The kinase reactions were termi-by forward and side scatter as well as their positive staining for
B220. These small B2201 lymphocytes consist of two distinct popu- nated by boiling in SDS sample buffer, and the proteins were
resolved by 12% SDS±polyacrylamide gel electrophoresis (acryl-lations of BrdU1 and BrdU2 cells. The data are presented as the
percentage of B2201 lymphocytes that are BrdU1. amide:bisacrylamide ratio 37.5:1). The resolving gel was either dried
on Whatman paper or transferred to nitrocellulose and subsequentlyIn Vitro Labeling
Splenocytes depleted of RBCs were plated in tissue culture medium exposed to film. Quantitation was achieved by direct exposure to a
phosphor screen and analyzed using a PhosphorImager (Molecularat 0.5 3 106 cells/ml in the presence of anti-IgM or LPS. Cells were
labeled with BrdU (10 mM) from 24 to 48 hr poststimulation and Dynamics, Sunnyvale, CA).
stained for B220 and BrdU at the end of the labeling period, following
the same procedure as above. Autoantibodies
Autoantibodies directed against nuclear antigens or dsDNA were
detected in the serum by immunofluorescence or enzyme-linkedPurification of Splenic B Lymphocytes
Splenic B lymphocytes from 7- to 11-week-old mice were prepared immunosorbent assay (ELISA) assay, respectively. For titers of auto-
antibodies directed against nuclear antigens, serum was dilutedas described (DeFranco et al., 1982) except that anti-Thy1, anti-
CD8, and anti-CD4 were used in combination for the complement 1:500 in phosphate-buffered saline (PBS) and incubated with slides
containing fixed HEp-2 cells (Sanofi Diagnostics) for 30 min at roomlysis of T cells. Cells that were collected from the 50%/70% Percoll
interphase were washed and subsequently rested in tissue culture temperature. Slides were washed three times in PBS, and autoanti-
bodies were detected by incubation with fluorescein isothiocya-medium for 3 hr in tissue culture dishes (Corning 25020) prior to all
stimulations. The purity of each of the splenic B cell preparations nate±labeled rabbit anti-mouse immunoglobulin. Nuclear staining
was considered positive only if it was present in a diffuse, homoge-was verified by flow cytometric analysis and was typically equal to
or greater than 84% B2201 from lyn2/2 mice and equal to or greater nous pattern (with or without rim staining). Speckled nuclear staining
was scored negative. Anti-dsDNA autoantibodies were detected bythan 93% from wild-type mice.
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ELISA assay using the Bindazyme kit (Binding Site) as described Goodnow, C.G. (1996). Regulation of B-lymphocyte negative and
positive selection by tyrosine phosphatase CD45. Nature 381,by the manufacturer. Mouse sera were diluted 1:1000 in PBS and
incubated with the dsDNA coated wells, and binding was quanti- 325±328.
tated using horseradish peroxidase±labeled anti-mouse IgM or IgG. D'Ambrosio, D., Hippen, K.H., Minskoff, S.A., Mellman, I., Pani, G.,
All ELISAs were done in triplicate. Data are reported as absorbance Siminovitch, K.A., and Cambier, J.C. (1995). Recruitment and activa-
at 450 nm (A450) after 30 min of color development. Wild-type mice tion of PTP1C in negative regulation of antigen receptor signaling
showed no anti-dsDNA autoantibodies at any age. by FcgRIIB1. Science 268, 293±296.
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